FAKTOR-OPTIONSSCHEIN - LABCORP HOLDINGS Stock

Certificat

DE000MG4P850

Market Closed - Börse Stuttgart 04:49:50 2024-07-11 am EDT
10.26 EUR -8.15% Intraday chart for FAKTOR-OPTIONSSCHEIN - LABCORP HOLDINGS
Current month+9.73%
1 month-24.50%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 10.26 -8.15%
24-07-10 11.17 +19.98%
24-07-09 9.31 -3.52%
24-07-08 9.65 +5.01%
24-07-05 9.19 -1.18%

Delayed Quote Börse Stuttgart

Last update July 11, 2024 at 04:49 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying LABCORP HOLDINGS INC.
Issuer Morgan Stanley
WKN MG4P85
ISINDE000MG4P850
Date issued 2024-05-22
Strike 225.4 $
Maturity Unlimited
Parity 2.14 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 16.75
Lowest since issue 8.01

Company Profile

Labcorp Holdings Inc. provides comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company serves clients in more than 100 countries.
Sector
-
More about the company

Ratings for Labcorp Holdings Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Labcorp Holdings Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
206.2 USD
Average target price
238.1 USD
Spread / Average Target
+15.46%
Consensus